The "e-RESATER Final Evaluation Report" to summarize and provide an assessment of the activities carried out in the context of the e-RESATER project is now available in VITLAB.
e-RESATER is a project belonging to the INTERREG IV B program. The project has run for 30 months (since January 2013 to June 2015).
"Open Innovation: Beyond the traditional innovation" is the title of a report launched by the OBEA research Group in the University of Mondragon. The report highlighted the inadequacy of the traditional system of innovation focused on the product to maintain the competitiveness of organizations in today's ecosystem. This information is also valid for the Health Sectors and Ecosystems.
Full Report accessible here
The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by the pharmaceutical industry association EFPIA). IMI is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need.